4//SEC Filing
Hering David 4
Accession 0000899243-22-025328
CIK 0001832038other
Filed
Jul 5, 8:00 PM ET
Accepted
Jul 6, 4:05 PM ET
Size
9.5 KB
Accession
0000899243-22-025328
Insider Transaction Report
Form 4
Hering David
Chief Operating Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-07-05+2,000,000→ 2,000,000 totalExercise: $3.37Exp: 2032-07-04→ Common Stock (2,000,000 underlying)
Footnotes (1)
- [F1]This option vests in equal monthly installments over a period of 48 months with the first vesting date occurring on August 5, 2022, subject to the Reporting Person's continuous service as of the applicable vesting date.
Issuer
Adagio Therapeutics, Inc.
CIK 0001832038
Entity typeother
Related Parties
1- filerCIK 0001875613
Filing Metadata
- Form type
- 4
- Filed
- Jul 5, 8:00 PM ET
- Accepted
- Jul 6, 4:05 PM ET
- Size
- 9.5 KB